Literature DB >> 29727496

Errors in 1 H-MRS estimates of brain metabolite concentrations caused by failing to take into account tissue-specific signal relaxation.

Charles Gasparovic1, Hongji Chen2, Paul G Mullins3.   

Abstract

Accurate measurement of brain metabolite concentrations with proton magnetic resonance spectroscopy (1 H-MRS) can be problematic because of large voxels with mixed tissue composition, requiring adjustment for differing relaxation rates in each tissue if absolute concentration estimates are desired. Adjusting for tissue-specific metabolite signal relaxation, however, also requires a knowledge of the relative concentrations of the metabolite in gray (GM) and white (WM) matter, which are not known a priori. Expressions for the estimation of the molality and molarity of brain metabolites with 1 H-MRS are extended to account for tissue-specific relaxation of the metabolite signals and examined under different assumptions with simulated and real data. Although the modified equations have two unknowns, and hence are unsolvable explicitly, they are nonetheless useful for the estimation of the effect of tissue-specific metabolite relaxation rates on concentration estimates under a range of assumptions and experimental parameters using simulated and real data. In simulated data using reported GM and WM T1 and T2 times for N-acetylaspartate (NAA) at 3 T and a hypothetical GM/WM NAA ratio, errors of 6.5-7.8% in concentrations resulted when TR = 1.5 s and TE = 0.144 s, but were reduced to less than 0.5% when TR = 6 s and TE = 0.006 s. In real data obtained at TR/TE = 1.5 s/0.04 s, the difference in the results (4%) was similar to that obtained with simulated data when assuming tissue-specific relaxation times rather than GM-WM-averaged times. Using the expressions introduced in this article, these results can be extrapolated to any metabolite or set of assumptions regarding tissue-specific relaxation. Furthermore, although serving to bound the problem, this work underscores the challenge of correcting for relaxation effects, given that relaxation times are generally not known and impractical to measure in most studies. To minimize such effects, the data should be acquired with pulse sequence parameters that minimize the effect of signal relaxation.
Copyright © 2018 John Wiley & Sons, Ltd.

Entities:  

Keywords:  brain; magnetic resonance spectroscopy; metabolite relaxation

Mesh:

Substances:

Year:  2018        PMID: 29727496     DOI: 10.1002/nbm.3914

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  9 in total

1.  Reproducibility of 7-T brain spectroscopy using an ultrashort echo time STimulated Echo Acquisition Mode sequence and automated voxel repositioning.

Authors:  Meredith A Reid; Martha R Forloines; Nouha Salibi
Journal:  NMR Biomed       Date:  2021-10-08       Impact factor: 4.044

2.  Glutamate levels in the anterior cingulate cortex in un-medicated first episode psychosis: a proton magnetic resonance spectroscopy study.

Authors:  Faith R Borgan; Sameer Jauhar; Robert A McCutcheon; Fiona S Pepper; Maria Rogdaki; David J Lythgoe; Oliver D Howes
Journal:  Sci Rep       Date:  2019-07-02       Impact factor: 4.379

3.  GABA quantification in human anterior cingulate cortex.

Authors:  Jan Weis; Jonas Persson; Andreas Frick; Fredrik Åhs; Maarten Versluis; Daniel Alamidi
Journal:  PLoS One       Date:  2021-01-15       Impact factor: 3.240

4.  The effect of antipsychotics on glutamate levels in the anterior cingulate cortex and clinical response: A 1H-MRS study in first-episode psychosis patients.

Authors:  Uzma Zahid; Robert A McCutcheon; Faith Borgan; Sameer Jauhar; Fiona Pepper; Matthew M Nour; Maria Rogdaki; Martin Osugo; Graham K Murray; Pamela Hathway; Robin M Murray; Oliver D Howes
Journal:  Front Psychiatry       Date:  2022-08-11       Impact factor: 5.435

5.  Preprocessing, analysis and quantification in single-voxel magnetic resonance spectroscopy: experts' consensus recommendations.

Authors:  Jamie Near; Ashley D Harris; Christoph Juchem; Roland Kreis; Małgorzata Marjańska; Gülin Öz; Johannes Slotboom; Martin Wilson; Charles Gasparovic
Journal:  NMR Biomed       Date:  2020-02-21       Impact factor: 4.044

6.  The clinical utility of proton magnetic resonance spectroscopy in traumatic brain injury: recommendations from the ENIGMA MRS working group.

Authors:  Brenda L Bartnik-Olson; Jeffry R Alger; Talin Babikian; Ashley D Harris; Barbara Holshouser; Ivan I Kirov; Andrew A Maudsley; Paul M Thompson; Emily L Dennis; David F Tate; Elisabeth A Wilde; Alexander Lin
Journal:  Brain Imaging Behav       Date:  2021-04       Impact factor: 3.978

7.  FSL-MRS: An end-to-end spectroscopy analysis package.

Authors:  William T Clarke; Charlotte J Stagg; Saad Jbabdi
Journal:  Magn Reson Med       Date:  2020-12-06       Impact factor: 3.737

8.  Exploring Changes in Thalamus Metabolites as Diagnostic Biomarkers in Idiopathic Generalised Epilepsy Patients Using Magnetic Resonance Spectroscopy.

Authors:  Razzagh Abedi-Firouzjah; Ayoob Rostamzadeh; Amin Banaei; Mohsen Shafiee; Zafar Masoumi Moghaddam; Hassan Vafapour
Journal:  Malays J Med Sci       Date:  2020-02-27

9.  Association between cannabinoid 1 receptor availability and glutamate levels in healthy controls and drug-free patients with first episode psychosis: a multi-modal PET and 1H-MRS study.

Authors:  Faith Borgan; Mattia Veronese; Tiago Reis Marques; David J Lythgoe; Oliver Howes
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-09-28       Impact factor: 5.270

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.